JETEMA, Co., Ltd. (KOSDAQ:216080)
South Korea · Delayed Price · Currency is KRW 8,650.00
+130.00 (1.53%)
At close: Mar 20, 2026
JETEMA, Market Cap
JETEMA, has a market cap or net worth of 315.74 billion as of March 20, 2026. Its market cap has increased by 34.48% in one year.
Market Cap
315.74B
Enterprise Value
421.82B
Revenue
75.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,650.00
Market Cap Chart
Since November 14, 2019, JETEMA,'s market cap has increased from 129.11B to 315.74B, an increase of 144.56%. That is a compound annual growth rate of 15.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 315.74B | 43.28% |
| Dec 30, 2025 | 220.37B | -20.54% |
| Dec 30, 2024 | 277.33B | -0.13% |
| Dec 28, 2023 | 277.70B | 19.01% |
| Dec 29, 2022 | 233.35B | -35.77% |
| Dec 30, 2021 | 363.31B | -9.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 488.97B |
| SillaJen | 484.84B |
| Anterogen.Co.,Ltd. | 434.26B |
| BINEX | 414.02B |
| GC Cell | 398.97B |
| Bioneer | 313.34B |
| HLB Therapeutics | 275.93B |
| Helixmith | 260.63B |